SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-013803
Filing Date
2024-02-12
Accepted
2024-02-12 16:00:17
Documents
14
Period of Report
2024-02-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-20240212.htm   iXBRL 8-K 49790
2 EX-99.1 sybx-ex99_1.htm EX-99.1 18241
3 GRAPHIC img56602281_0.jpg GRAPHIC 24476
  Complete submission text file 0000950170-24-013803.txt   234828

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sybx-20240212.xsd EX-101.SCH 33138
15 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20240212_htm.xml XML 4872
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 24619738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)